Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease

被引：0
|
作者：
Brohee, Sacha [1 ]
Roze, Emmanuel [1 ]
Grabli, David [1 ]
Letrillart, Helene [1 ]
Mantisi, Lise [1 ]
Foucard, Cendrine [1 ]
Hainque, Elodie [1 ]
Cormier, Florence [1 ]
Meneret, Aurelie [1 ]
Hauw, Fabien [1 ]
机构：
[1] Hop La Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Dept Neurol, Paris, France
来源：
MOVEMENT DISORDERS CLINICAL PRACTICE | 2025年
关键词：
Parkinson's disease; foslevodopa; hallucinations; confusion; delirium;
D O I：
10.1002/mdc3.70060
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Patients’ experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson’s disease
    Michael Soileau
    Rajeev Kumar
    Ashwini Parab
    Triza Brion
    Kailee White
    Connie H. Yan
    Megha B. Shah
    Pavnit Kukreja
    Maurizio F. Facheris
    Anand Shewale
    Jason Aldred
    Journal of Neurology, 2025, 272 (6)
  • [2] Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance
    Fung, Victor S. C.
    Aldred, Jason
    Arroyo, Martha P.
    Bergquist, Filip
    Boon, Agnita J. W.
    Bouchard, Manon
    Bray, Sarah
    Dhanani, Sara
    Facheris, Maurizio F.
    Fisseha, Nahome
    Freire-Alvarez, Eric
    Hauser, Robert A.
    Jeong, Anna
    Jia, Jia
    Kukreja, Pavnit
    Soileau, Michael J.
    Spiegel, Amy M.
    Talapala, Saritha
    Tarakad, Arjun
    Urrea-Mendoza, Enrique
    Zamudio, Jorge
    Pahwa, Rajesh
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 10
  • [3] A patient with Parkinson's disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/ foscarbidopa infusion
    Sakuramoto, Hirotaka
    Fujita, Hiroaki
    Ogaki, Keitaro
    Suzuki, Keisuke
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 11
  • [4] Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK
    Chaudhuri, K. Ray
    Bergmann, Lars
    Belsey, Jonathan
    Boodhna, Trishal
    Leoncini, Emanuele
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1267 - 1278
  • [5] Continuous Subcutaneous Foslevodopa-Foscarbidopa in Parkinson's Disease: A Mini-Review of Current Scope and Future Outlook
    Aubignat, Mickael
    Tir, Melissa
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (10): : 1188 - 1194
  • [6] Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson’s Disease
    Adam Nassery
    Christina A. Palmese
    Harini Sarva
    Mark Groves
    Joan Miravite
    Brian Harris Kopell
    Current Neurology and Neuroscience Reports, 2016, 16
  • [7] Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease
    Nassery, Adam
    Palmese, Christina A.
    Sarva, Harini
    Groves, Mark
    Miravite, Joan
    Kopell, Brian Harris
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (10)
  • [8] Psychiatric and cognitive disorders in Parkinson's disease
    Nilsson, FM
    CURRENT OPINION IN PSYCHIATRY, 2004, 17 (03) : 197 - 202
  • [9] Psychiatric and cognitive disturbances in Parkinson's disease - Therapeutic options
    Baronti, F
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 2002, 91 (10): : 411 - 417
  • [10] Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
    Aarsland, D
    Hutchinson, M
    Larsen, JP
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) : 937 - 941
12345